Evaluation and refinement of all-atom force fields for reproducing collagen structure and dynamics

评估和改进用于重现胶原蛋白结构和动力学的全原子力场

阅读:1

Abstract

Collagenous protein domains, characterized by the XYGly sequence repeat motif, trimerize and fibrilize to serve as the molecular skeleton of extracellular matrices, and their mutations are frequently associated with disease. Because of experimental challenges in studying the effect of mutations on the properties of collagen, accurate atomistic molecular dynamics simulations are an invaluable tool. We evaluate the accuracy of state-of-the-art molecular dynamics force fields using recent experiments on model peptide homotrimers composed of proline-4(R)-hydroxyproline-glycine (POG) repeats: the stabilizing POG motif appears with high frequency in several types of collagen. POG repeats are used as templates to explore the role of amino acid substitutions in modulating collagen structure. We have compared the structure and dynamics of collagen POG(10) homotrimers with various force fields from the CHARMM, AMBER, and GROMOS families together with various water models to aggregated crystal structure data, NMR data, and small-angle X-ray scattering (SAXS) form factors. Of the tested force fields, we find those from AMBER and CHARMM give an acceptable description of collagen structure. AMBER force fields accurately reproduce collagen dihedrals, side-chain torsions, amide spin relaxations, and SAXS data. CHARMM force fields were found to systematically shift backbone ϕ and ψ dihedrals, adopt incorrect side-chain torsional angles, and overstructure POG(10), increasing the persistence length relative to POG(10) in AMBER force fields. However, by scaling the CHARMM36 CMAP terms of all dihedrals in POG(10), we are able to capture a level of accuracy relative to experiment similar to that for the AMBER force fields. We suggest the use of AMBER ff99sb force fields or CHARMM36 with CMAP terms involving Pro, Hyp, and Gly rescaled by a factor of 1/2 (which we term CHARMM36mGP) for modeling collagen-like peptides.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。